226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.05%
Net income growth at 50-75% of JD's 10.51%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
6.77%
D&A growth of 6.77% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-97.83%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
77.12%
SBC growth of 77.12% while JD is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
60.88%
Working capital change of 60.88% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-190.22%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-231.75%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
178.05%
AP growth of 178.05% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-19.41%
Negative yoy usage while JD is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
55.34%
Some yoy increase while JD is negative at -301.39%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
91.10%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-28.63%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-3641.67%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-33.48%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
47.87%
Liquidation growth of 47.87% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
6.68%
Less 'other investing' outflow yoy vs. JD's 248.67%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-32.28%
We reduce yoy invests while JD stands at 230.06%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-940.43%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.